Atoltivimab

Atoltivimab is a Zaire ebolavirus glycoprotein-directed human monoclonal antibody that is part of the fixed-dose combination atoltivimab/maftivimab/odesivimab that is used for the treatment of Zaire ebolavirus (Ebola virus).^[1][2][3]

Atoltivimab

Monoclonal antibody
Type	Whole antibody
Source	Human
Target	Zaire ebolavirus glycoprotein
Clinical data
Pronunciation	a" tol tiv' i mab
License data	US DailyMed: Atoltivimab
Drug class	Monoclonal antibody
ATC code	None
Identifiers
CAS Number	2135632-29-8
UNII	FJZ07Q63VY
KEGG	D11468
Chemical and physical data
Formula	C6448H9954N1726O2002S44
Molar mass	145097.28 g·mol−1